GAR1-DT
gene geneOn this page
Summary
GAR1-DT (GAR1 divergent transcript, HGNC:55191) is a long non-coding RNA gene on chromosome 4q25.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:55191 |
| Approved symbol | GAR1-DT |
| Name | GAR1 divergent transcript |
| Location | 4q25 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000272795 |
| Ensembl biotype | lncRNA |
| Entrez | 124900758 |
| RNAcentral | URS00026A1CA0 — lncRNA, 1234 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 13 lncRNA
ENST00000609440, ENST00000715265, ENST00000715266, ENST00000715267, ENST00000792247, ENST00000792248, ENST00000792249, ENST00000792250, ENST00000792251, ENST00000792252, ENST00000792253, ENST00000792254, ENST00000792255
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000609440 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004174097 | 109814831 | 109815511 |
| ENSE00004174099 | 109812916 | 109813600 |
Expression profiles
Bgee: expression breadth ubiquitous, 125 present calls, max score 86.16.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3549 / max 15.0808, expressed in 180 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 53610 | 0.3549 | 180 |
Top tissues by expression
125 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.16 | gold quality |
| cortical plate | UBERON:0005343 | 72.03 | gold quality |
| ganglionic eminence | UBERON:0004023 | 71.38 | gold quality |
| colonic epithelium | UBERON:0000397 | 71.32 | gold quality |
| bone marrow cell | CL:0002092 | 71.00 | gold quality |
| stromal cell of endometrium | CL:0002255 | 70.52 | gold quality |
| left testis | UBERON:0004533 | 70.35 | gold quality |
| right testis | UBERON:0004534 | 70.10 | gold quality |
| testis | UBERON:0000473 | 69.72 | gold quality |
| bone marrow | UBERON:0002371 | 69.49 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 67.26 | gold quality |
| right uterine tube | UBERON:0001302 | 67.23 | gold quality |
| substantia nigra | UBERON:0002038 | 66.59 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 66.19 | gold quality |
| hypothalamus | UBERON:0001898 | 66.07 | gold quality |
| nucleus accumbens | UBERON:0001882 | 65.95 | gold quality |
| amygdala | UBERON:0001876 | 65.39 | gold quality |
| putamen | UBERON:0001874 | 64.98 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 64.42 | gold quality |
| primary visual cortex | UBERON:0002436 | 64.40 | gold quality |
| caudate nucleus | UBERON:0001873 | 64.20 | gold quality |
| prefrontal cortex | UBERON:0000451 | 64.14 | gold quality |
| right frontal lobe | UBERON:0002810 | 63.98 | gold quality |
| brain | UBERON:0000955 | 63.96 | gold quality |
| frontal cortex | UBERON:0001870 | 63.82 | gold quality |
| Ammon’s horn | UBERON:0001954 | 63.78 | gold quality |
| pituitary gland | UBERON:0000007 | 63.77 | gold quality |
| cerebral cortex | UBERON:0000956 | 63.74 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 63.74 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 63.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.95 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.